Related Experiment Video
Updated: May 5, 2026

A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.
Published on: June 14, 2015
Synthetic-Polymer-Based Cardiac Patches for MI-Induced Heart Failure Treatment: A Review
Ahmed Eliwa1,2, Mohamed K Abbas3, Maryam Al-Ejji3
1College of Medicine, Qatar University, Doha P.O. Box 2713, Qatar.
Synthetic polymer cardiac patches offer a promising treatment for heart failure following myocardial infarction (MI). These advanced scaffolds improve cardiac function and provide mechanical support, addressing critical needs in cardiovascular disease therapy.
Area of Science:
- Biomedical Engineering
- Materials Science
- Cardiovascular Research
Background:
- Myocardial infarction (MI) leads to heart failure due to cardiac tissue damage.
- Cardiac patches are polymer scaffolds designed to repair heart tissue and improve function.
- Current research focuses on synthetic polymers for advanced cardiac patch fabrication.
Purpose of the Study:
- To review recent advancements in synthetic-polymer-based cardiac patches for treating MI-induced heart failure.
- To analyze the mechanical and chemical properties of various synthetic polymers used in cardiac patches.
- To outline challenges and future directions in cardiac patch technology.
Main Methods:
- Literature review of synthetic polymer cardiac patches for myocardial infarction.
- Analysis of mechanical and chemical characteristics of different synthetic polymers.
- Discussion of benefits, drawbacks, challenges, and future prospects.
Main Results:
- Synthetic polymer cardiac patches demonstrate significant therapeutic effects in preclinical models.
- Specific polymers offer distinct advantages in terms of mechanical support and bioactive substance delivery.
- Key challenges include long-term stability, integration with host tissue, and scalable manufacturing.
Conclusions:
- Synthetic polymer cardiac patches represent a viable strategy for mitigating heart failure post-MI.
- Tailoring polymer properties is crucial for optimizing patch performance and patient outcomes.
- Continued innovation is needed to overcome current limitations and advance clinical translation.
Related Concept Videos
Myocarditis III: Medical Management
Heart Failure Drugs: Inotropic Agents
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy

